Loading company…
MITOCH develops stem cell therapies for age-related diseases in cats and dogs.
Founded in 2021 and based in Shanghai, MITOCH develops stem cell drugs for age-related diseases in cats and dogs. Its programs include mesenchymal stem cell treatments for muscular dystrophy, inflammatory bowel disease, and osteoarthritis. Founder and CEO Dr. Yu Ren graduated from the Chinese Academy of Sciences, and the team includes members from that institution, Tsinghua University, and China Agricultural University. In April 2025, it closed a pre-Series A funding round led by Triwise Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in